Author [ Title(Desc)] Type Year
Filters: Author is Jordan N Smith  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Stoddard EG, Killinger BJ, Nair RN, Sadler NC, Volk RF, Purvine SO, et al.. Activity-Based Probes for Isoenzyme- and Site-Specific Functional Characterization of Glutathione S-Transferases. J Am Chem Soc. 2017 ;139(45):16032-16035.
H
Sadler NC, Nandhikonda P, Webb-Robertson B-J, Ansong C, Anderson LN, Smith JN, et al.. Hepatic Cytochrome P450 Activity, Abundance, and Expression Throughout Human Development. Drug Metab Dispos. 2016 ;44(7):984-91.
I
Smith JN, Mehinagic D, Nag S, Crowell SRitger, Corley RA. In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes. Toxicol Lett. 2017 ;269:23-32.
M
Stoddard EG, Volk RF, Carson JP, Ljungberg CM, Murphree TA, Smith JN, et al.. Multifunctional Activity-Based Protein Profiling of the Developing Lung. J Proteome Res. 2018 ;17(8):2623-2634.
P
Hummel JM, Madeen EP, Siddens LK, Uesugi S, McQuistan TJ, Anderson KA, et al.. Pharmacokinetics of [C]-Benzo[a]pyrene (BaP) in humans: Impact of Co-Administration of smoked salmon and BaP dietary restriction. Food Chem Toxicol. 2018 ;115:136-147.
T
Madeen EP, Siddens LK, Uesugi S, McQuistan TJ, Corley RA, Smith JN, et al.. Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing. Toxicol Appl Pharmacol. 2019 ;364:97-105.